ALTHAM, Mass. — Repligen Corporation (NASDAQ:RGEN) today announced the appointment of life sciences industry executive Rohin Mhatre, Ph.D., to its Board of Directors. Dr. Mhatre brings to the director role over 25 years of relevant experience, which includes his current position as Senior Vice President, Product and Technology Development for Biogen Inc., a leading multinational […]
WALTHAM, Mass. — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its board of directors has elected president and chief executive officer Marc N. Casper, 51, as chairman, effective immediately. Casper will continue in his role as president and chief executive officer, which he has held since October […]
Tim Hohm to further develop Optibrium’s sales and business strategy for global market expansion CAMBRIDGE, UK – Optibrium™, a developer of software for drug discovery, today announced the appointment of Dr Tim Hohm as Director of Commercial Strategy and Business Development. Tim will be responsible for leading the Company’s commercial strategy and sales processes, with a […]
LAUSANNE, Switzerland & BOSTON–SOPHiA GENETICS, leader in Data-Driven Medicine, announced today the appointment of Philippe Menu, MD-PhD, MBA, as Chief Medical Officer. Dr. Philippe Menu brings a unique blend of medical expertise across multiple areas including clinical medicine, fundamental research in molecular biology, and management consulting. He spent the last eight years at McKinsey & […]
SAN DIEGO – TriLink BioTechnologies®, a Maravai LifeSciences company and a leader in the production of nucleic acids for research, diagnostics and therapeutics applications, announced today the addition of two key executives to its leadership team. Ray Kaczmarek joins TriLink as senior vice president of GMP Operations. Kaczmarek, who has over 20 years of experience […]
Dr. Denis Zaccarin Succeeds Phillips to Lead Research and Development MENLO PARK, Calif. — Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced that Michael Phillips has decided to retire from his role as the company’s Senior Vice President of Research and Development as of […]
SAN DIEGO–Illumina, Inc. (NASDAQ: ILMN) announced today that Scott Gottlieb, M.D. has joined the company’s Board of Directors, effective February 4, 2020. Dr. Gottlieb is currently a special partner at the venture capital firm New Enterprise Associates (NEA) and a resident fellow at the American Enterprise Institute (AEI). From 2017 to 2019, he served as […]
We proudly announce the extension of our product portfolio with the Kinexus rotational rheometers and Rosand capillary rheometers formerly manufactured and distributed by Malvern Panalytical Limited (“Malvern Panalytical”). NETZSCH and Malvern Panalytical look back on many years of close collaboration, making the acquisition of Malvern Panalytical’s rheology business a natural step in this journey. For […]
Applied Photophysics Limited, a world leader in biophysical characterization of biomolecules, has today announced that its Board of Directors has appointed Tim Flanagan as Chief Executive Officer and member of the Board of Directors effective immediately. Additionally, Marc Neglia has been appointed President of Applied Photophysics Inc. to lead operations in the Americas and will […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
